Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2022

01-02-2022 | Care | Research Article

A qualitative exploration of the healthcare challenges and pharmaceutical care needs of people with Parkinson’s and their caregivers

Authors: Sabrina Anne Jacob, Zhi Jean Wong, Wing Loong Cheong, Elizabeth Yie-Chuen Chong, Yin Xuan Wong, Sara Lai Heong Lew

Published in: International Journal of Clinical Pharmacy | Issue 1/2022

Login to get access

Abstract

Background People with Parkinson’s are at higher risk of healthcare and pharmaceutical care issues. Objective To determine the healthcare challenges, pharmaceutical care needs, and perceived need of a pharmacist-run clinic by people with Parkinson’s and their caregivers. Setting Malaysian Parkinson’s Disease Association. Method A focus group discussion adopting a descriptive qualitative approach was conducted involving people with Parkinson’s and their caregivers. A semi-structured interview guide was used to determine the challenges they faced with their medications and healthcare system, their pharmaceutical care needs, and their views on a pharmacist-run clinic. Data was thematically analysed. Main outcome measure: Healthcare challenges faced by people with Parkinson’s and caregivers along with their pharmaceutical care needs and perceived need of a pharmacist-run clinic. Results Nine people with Parkinson’s and four caregivers participated. Six themes were developed: (1) “It’s very personalised”: the need for self-experimentation, (2) “Managing it is quite difficult”: challenges with medication, (3) “The doctor has no time for you”: challenges with healthcare providers, (4) “Nobody can do it except me”: challenges faced by caregivers, (5) “It becomes a burden”: impact on quality of life, and (6) “Lack of consistency could be counterproductive”: views on pharmacist-run clinic. Conclusion The provision of pharmaceutical care services by pharmacists could help overcome issues people with Parkinson’s face, however there is a need for them to first see pharmacists in their expanded roles and change their limited perception of pharmacists. This can be achieved through integration of pharmacists within multidisciplinary teams in specialist clinics which they frequent.
Appendix
Available only for authorised users
Literature
1.
go back to reference GBD Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–97.CrossRef GBD Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–97.CrossRef
2.
go back to reference Bainbridge JL, Ruscin JM. Challenges of treatment adherence in older patients with Parkinson’s disease. Drugs Aging. 2009;26(2):145–55.CrossRef Bainbridge JL, Ruscin JM. Challenges of treatment adherence in older patients with Parkinson’s disease. Drugs Aging. 2009;26(2):145–55.CrossRef
3.
go back to reference Schröder S, Martus P, Odin P, Schaefer M. Drug-related problems in Parkinson’s disease: the role of community pharmacists in primary care. Int J Clin Pharm. 2011;33(4):674–82.CrossRef Schröder S, Martus P, Odin P, Schaefer M. Drug-related problems in Parkinson’s disease: the role of community pharmacists in primary care. Int J Clin Pharm. 2011;33(4):674–82.CrossRef
4.
go back to reference Foppa AA, Chemello C, Vargas-Peláez CM, Farias MR. Medication therapy management service for patients with Parkinson's disease: a before-and-after study. Neurol Ther. 2016;5(1):85–99.CrossRef Foppa AA, Chemello C, Vargas-Peláez CM, Farias MR. Medication therapy management service for patients with Parkinson's disease: a before-and-after study. Neurol Ther. 2016;5(1):85–99.CrossRef
5.
go back to reference Grosset D, Antonini A, Canesi M, Pezzoli G, Lees A, Shaw K, et al. Adherence to antiparkinson medication in a multicenter European study. Mov Disord. 2009;24(6):826–32.CrossRef Grosset D, Antonini A, Canesi M, Pezzoli G, Lees A, Shaw K, et al. Adherence to antiparkinson medication in a multicenter European study. Mov Disord. 2009;24(6):826–32.CrossRef
6.
go back to reference National Collaborating Centre for Chronic Conditions. Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care. Great Britain: Royal College of Physicians ISBN: 1-86016-283-5; 2006. National Collaborating Centre for Chronic Conditions. Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care. Great Britain: Royal College of Physicians ISBN: 1-86016-283-5; 2006.
7.
go back to reference Wright J, Walker J. Medication adherence in Parkinson’s. Br J Nurs. 2013;22(12):686–9.CrossRef Wright J, Walker J. Medication adherence in Parkinson’s. Br J Nurs. 2013;22(12):686–9.CrossRef
8.
go back to reference Schröder S, Martus P, Odin P, Schaefer M. Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson’s disease. Int J Clin Pharm. 2012;34(5):746–56.CrossRef Schröder S, Martus P, Odin P, Schaefer M. Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson’s disease. Int J Clin Pharm. 2012;34(5):746–56.CrossRef
9.
go back to reference Davis KL, Edin HM, Allen JK. Prevalence and cost of medication nonadherence in Parkinson’s disease: Evidence from administrative claims data. Mov Disord. 2010;25(4):474–80.CrossRef Davis KL, Edin HM, Allen JK. Prevalence and cost of medication nonadherence in Parkinson’s disease: Evidence from administrative claims data. Mov Disord. 2010;25(4):474–80.CrossRef
10.
go back to reference van der Eijk M, Faber MJ, Post B, Okun MS, Schmidt P, Munneke M, et al. Capturing patients’ experiences to change Parkinson’s disease care delivery: a multicenter study. J Neurol. 2015;262(11):2528–38.CrossRef van der Eijk M, Faber MJ, Post B, Okun MS, Schmidt P, Munneke M, et al. Capturing patients’ experiences to change Parkinson’s disease care delivery: a multicenter study. J Neurol. 2015;262(11):2528–38.CrossRef
11.
go back to reference van der Eijk M, Faber MJ, Al Shamma S, Munneke M, Bloem BR. Moving towards patient-centered healthcare for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(5):360–4.CrossRef van der Eijk M, Faber MJ, Al Shamma S, Munneke M, Bloem BR. Moving towards patient-centered healthcare for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(5):360–4.CrossRef
13.
go back to reference Viswanathan M, Ammerman A, Eng E, Garlehner G, Lohr KN, Griffith D, et al. Community‐Based Participatory Research: Assessing the Evidence; Evidence Report/Technology Assessment No 9. AHRQ Evidence Report Summaries 1998–2005. Rockville, MD: Agency for Healthcare Research and Quality 2004. Viswanathan M, Ammerman A, Eng E, Garlehner G, Lohr KN, Griffith D, et al. Community‐Based Participatory Research: Assessing the Evidence; Evidence Report/Technology Assessment No 9. AHRQ Evidence Report Summaries 1998–2005. Rockville, MD: Agency for Healthcare Research and Quality 2004.
14.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
15.
go back to reference Feenberg A. On being a human subject: interest and obligation in the experimental treatment of incurable disease. Philos Forum. 1992;23:213–30. Feenberg A. On being a human subject: interest and obligation in the experimental treatment of incurable disease. Philos Forum. 1992;23:213–30.
16.
go back to reference Titova N, Chaudhuri KR. Personalized medicine in Parkinson’s disease: time to be precise. Mov Disord. 2017;32(8):1147–54.CrossRef Titova N, Chaudhuri KR. Personalized medicine in Parkinson’s disease: time to be precise. Mov Disord. 2017;32(8):1147–54.CrossRef
17.
go back to reference Riggare S, Hägglund M. Precision medicine in Parkinson's disease—exploring patient-initiated self-tracking. J Parkinsons Dis. 2018;8(3):441–6.CrossRef Riggare S, Hägglund M. Precision medicine in Parkinson's disease—exploring patient-initiated self-tracking. J Parkinsons Dis. 2018;8(3):441–6.CrossRef
18.
go back to reference Chan FW-k, Wong FY-y, So WY, Kung K, Wong CK-m. How much do elders with chronic conditions know about their medications? BMC Geriatr. 2013;13:59. Chan FW-k, Wong FY-y, So WY, Kung K, Wong CK-m. How much do elders with chronic conditions know about their medications? BMC Geriatr. 2013;13:59.
19.
go back to reference Nair K, Dolovich L, Cassels A, McCormack J, Levine M, Gray J, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104–10. Nair K, Dolovich L, Cassels A, McCormack J, Levine M, Gray J, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104–10.
20.
go back to reference Woodward SC, Bereznicki BJ, Westbury JL, Bereznicki LRE. The effect of knowledge and expectations on adherence to and persistence with antidepressants. Patient Prefer Adherence. 2016;10:761–8.CrossRef Woodward SC, Bereznicki BJ, Westbury JL, Bereznicki LRE. The effect of knowledge and expectations on adherence to and persistence with antidepressants. Patient Prefer Adherence. 2016;10:761–8.CrossRef
21.
go back to reference Salama A, Yasin AE-R, Elbarbary W. Medication knowledge as a determinant of medication adherence in geriatric patients, Serse Elian City, Menoufia Governorate, Egypt. Menoufia Med J. 2017;30(1):63–8. Salama A, Yasin AE-R, Elbarbary W. Medication knowledge as a determinant of medication adherence in geriatric patients, Serse Elian City, Menoufia Governorate, Egypt. Menoufia Med J. 2017;30(1):63–8.
22.
go back to reference Buetow S, Giddings LS, Williams L, Nayar S. Perceived unmet needs for health care among Parkinson’s Society of New Zealand members with Parkinson’s disease. Parkinsonism Relat Disord. 2008;14(6):495–500.CrossRef Buetow S, Giddings LS, Williams L, Nayar S. Perceived unmet needs for health care among Parkinson’s Society of New Zealand members with Parkinson’s disease. Parkinsonism Relat Disord. 2008;14(6):495–500.CrossRef
23.
go back to reference Hayes C. Identifying important issues for people with Parkinson’s disease. Br J Nurs. 2002;11(2):91–7.CrossRef Hayes C. Identifying important issues for people with Parkinson’s disease. Br J Nurs. 2002;11(2):91–7.CrossRef
24.
go back to reference Ziegler DK, Mosier MC, Buenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians? JAMA Intern Med. 2001;161(5):706–13.CrossRef Ziegler DK, Mosier MC, Buenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians? JAMA Intern Med. 2001;161(5):706–13.CrossRef
25.
go back to reference Badger F, Nolan P. Concordance with antidepressant medication in primary care. Nurs Stand. 2006;20(52):35–40.CrossRef Badger F, Nolan P. Concordance with antidepressant medication in primary care. Nurs Stand. 2006;20(52):35–40.CrossRef
26.
go back to reference Hung SW, Adeli GM, Arenovich T, Fox SH, Lang AE. Patient perception of dyskinesia in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2010;81(10):1112–5.CrossRef Hung SW, Adeli GM, Arenovich T, Fox SH, Lang AE. Patient perception of dyskinesia in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2010;81(10):1112–5.CrossRef
27.
go back to reference Saw PS, Nissen LM, Freeman C, Wong PS, Mak V. Health care consumers’ perspectives on pharmacist integration into private general practitioner clinics in Malaysia: a qualitative study. Patient Prefer Adherence. 2015;9:467–77.CrossRef Saw PS, Nissen LM, Freeman C, Wong PS, Mak V. Health care consumers’ perspectives on pharmacist integration into private general practitioner clinics in Malaysia: a qualitative study. Patient Prefer Adherence. 2015;9:467–77.CrossRef
28.
go back to reference Awad A, Al-Rasheedi A, Lemay J, Public perceptions, expectations, and views of community pharmacy practice in Kuwait. Med Princ Pract. 2017;26(5):438–46.CrossRef Awad A, Al-Rasheedi A, Lemay J, Public perceptions, expectations, and views of community pharmacy practice in Kuwait. Med Princ Pract. 2017;26(5):438–46.CrossRef
29.
go back to reference Merks P, Świeczkowski D, Jaguszewski MJ. Patients’ perception of pharmaceutical services available in a community pharmacy among patients living in a rural area of the United Kingdom. Pharm Pract (Granada). 2016;14(3):774.CrossRef Merks P, Świeczkowski D, Jaguszewski MJ. Patients’ perception of pharmaceutical services available in a community pharmacy among patients living in a rural area of the United Kingdom. Pharm Pract (Granada). 2016;14(3):774.CrossRef
30.
go back to reference Erah PO, Chuks-Eboka NA. Patients’ perception of the benefits of pharmaceutical care services in the management of hypertension in a tertiary health care facility in Benin City. Trop J Pharm Res. 2008;7(1):897–905.CrossRef Erah PO, Chuks-Eboka NA. Patients’ perception of the benefits of pharmaceutical care services in the management of hypertension in a tertiary health care facility in Benin City. Trop J Pharm Res. 2008;7(1):897–905.CrossRef
31.
go back to reference You JH, Wong FY, Chan FW, Wong EL, Yeoh E-k. Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong. BMC Clin Pharmacol. 2011;11:19. You JH, Wong FY, Chan FW, Wong EL, Yeoh E-k. Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong. BMC Clin Pharmacol. 2011;11:19.
32.
go back to reference Hasan S, Sulieman H, Stewart K, Chapman CB, Kong DCM. Patient expectations and willingness to use primary care pharmacy services in the United Arab Emirates. Int J Pharm Pract. 2015;23(5):340–8.CrossRef Hasan S, Sulieman H, Stewart K, Chapman CB, Kong DCM. Patient expectations and willingness to use primary care pharmacy services in the United Arab Emirates. Int J Pharm Pract. 2015;23(5):340–8.CrossRef
33.
go back to reference El Hajj MS, Salem S, Mansoor H. Public’s attitudes towards community pharmacy in Qatar: a pilot study. Patient Prefer Adherence. 2011;5:405–22.CrossRef El Hajj MS, Salem S, Mansoor H. Public’s attitudes towards community pharmacy in Qatar: a pilot study. Patient Prefer Adherence. 2011;5:405–22.CrossRef
34.
go back to reference Fei CM. Public perception of the role of pharmacists and willingness to pay for pharmacist-provided dispensing services: a cross-sectional pilot study in the state of Sabah. Malaysia Malay J Pharm Sci. 2018;16(1):1–21.CrossRef Fei CM. Public perception of the role of pharmacists and willingness to pay for pharmacist-provided dispensing services: a cross-sectional pilot study in the state of Sabah. Malaysia Malay J Pharm Sci. 2018;16(1):1–21.CrossRef
35.
go back to reference Jose J, Al Shukili MN, Jimmy B. Public’s perception and satisfaction on the roles and services provided by pharmacists—cross sectional survey in Sultanate of Oman. Saudi Pharm J. 2015;23(6):635–41.CrossRef Jose J, Al Shukili MN, Jimmy B. Public’s perception and satisfaction on the roles and services provided by pharmacists—cross sectional survey in Sultanate of Oman. Saudi Pharm J. 2015;23(6):635–41.CrossRef
36.
go back to reference Majchrowska A, Bogusz R, Nowakowska L, Pawlikowski J, Piątkowski W, Wiechetek M. Public perception of the range of roles played by professional pharmacists. Int J Environ Res Public Health. 2019;16:2787.CrossRef Majchrowska A, Bogusz R, Nowakowska L, Pawlikowski J, Piątkowski W, Wiechetek M. Public perception of the range of roles played by professional pharmacists. Int J Environ Res Public Health. 2019;16:2787.CrossRef
37.
go back to reference Poon LH, Lee AJ, Chiao TB, Kang GA, Heath S, Glass GA. Pharmacist’s role in a Parkinson’s disease and movement disorders clinic. Am J Health Syst Pharm. 2012;69(6):518–20.CrossRef Poon LH, Lee AJ, Chiao TB, Kang GA, Heath S, Glass GA. Pharmacist’s role in a Parkinson’s disease and movement disorders clinic. Am J Health Syst Pharm. 2012;69(6):518–20.CrossRef
38.
go back to reference Shueb A. Pharmacist intervention in the management of Parkinson’s disease: evaluating the pharmacist’s intervention at a movement disorders outpatient clinic. Eur J Hosp Pharm. 2012;19(4):355–9.CrossRef Shueb A. Pharmacist intervention in the management of Parkinson’s disease: evaluating the pharmacist’s intervention at a movement disorders outpatient clinic. Eur J Hosp Pharm. 2012;19(4):355–9.CrossRef
39.
go back to reference Alrasheedy AA, Hassali MA, Wong ZY, Saleem F. Pharmacist-managed medication therapy adherence clinics: The Malaysian experience. Res Social Adm Pharm. 2017;13(4):885–6.CrossRef Alrasheedy AA, Hassali MA, Wong ZY, Saleem F. Pharmacist-managed medication therapy adherence clinics: The Malaysian experience. Res Social Adm Pharm. 2017;13(4):885–6.CrossRef
40.
go back to reference Bakar ZA, Fahrni ML, Khan TM. Patient satisfaction and medication adherence assessment amongst patients at the diabetes medication therapy adherence clinic. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S139–43.CrossRef Bakar ZA, Fahrni ML, Khan TM. Patient satisfaction and medication adherence assessment amongst patients at the diabetes medication therapy adherence clinic. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S139–43.CrossRef
41.
go back to reference Thanimalai S, Shafie AA, Hassali MA, Sinnadurai J. Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital. Int J Clin Pharm. 2013;35(5):736–43.CrossRef Thanimalai S, Shafie AA, Hassali MA, Sinnadurai J. Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital. Int J Clin Pharm. 2013;35(5):736–43.CrossRef
Metadata
Title
A qualitative exploration of the healthcare challenges and pharmaceutical care needs of people with Parkinson’s and their caregivers
Authors
Sabrina Anne Jacob
Zhi Jean Wong
Wing Loong Cheong
Elizabeth Yie-Chuen Chong
Yin Xuan Wong
Sara Lai Heong Lew
Publication date
01-02-2022
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2022
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-021-01312-4

Other articles of this Issue 1/2022

International Journal of Clinical Pharmacy 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine